The Role of the FDA in the National Cancer Program: Friend or Foe?
- 1 December 2003
- journal article
- editorial
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 8 (6) , 501-506
- https://doi.org/10.1634/theoncologist.8-6-501
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- End Points and United States Food and Drug Administration Approval of Oncology DrugsJournal of Clinical Oncology, 2003
- NCI Goal Aims for Cancer Victory by 2015Science, 2003
- The Case for a New National Program for the Development of Cancer TherapeuticsJournal of Clinical Oncology, 2001